Market Overview

The Global Glycobiology Market was valued at USD 1,005.7 million in 2023 and is expected to reach USD 3,163.1 million by 2031 while growing at a CAGR of 15.4% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global glycobiology market growth. Glycobiology is an interdisciplinary scientific field that explores the structure, biosynthesis, biology, and functions of carbohydrates (sugars) and glycoconjugates (carbohydrate-containing molecules) in biological systems. It encompasses diverse aspects of carbohydrate biology, including their roles in cellular processes, protein-carbohydrate interactions, glycan-mediated signaling pathways, and their involvement in biological functions.

Increasing research and development activities, coupled with the rising incidence of chronic diseases, drive the glycobiology market. However, the complexity of glycan analysis and the high cost of technologies hinder the growth of the market.

Furthermore, the global glycobiology industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Analysis

The Global Glycobiology Market is segmented among Enzymes, Instruments, and Kits and Reagents, based on Product. In 2023, Kits and Reagents accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Glycobiology Market is segmented among Diagnostics, Drug Discovery and Development, Oncology, Immunology, and Other Applications, based on Installation Type. In 2023, Drug Discovery and Development accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Glycobiology Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Agilent Technologies, Bruker Corporation, Danaher Corporation, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, Takara Bio, Thermo Fisher Scientific, and Waters Corporation.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Glycobiology Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Glycobiology Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Glycobiology Market Segmentation, By Product

• Global Glycobiology Market Share Analysis, By Product

• Global Glycobiology Market Growth Analysis, By Product

• Global Glycobiology Market Trends, By Product

o Enzymes

o Instruments

o Kits and Reagents

6. Global Glycobiology Market Segmentation, By Application

• Global Glycobiology Market Share Analysis, By Application

• Global Glycobiology Market Growth Analysis, By Application

• Global Glycobiology Market Trends, By Application

o Diagnostics

o Drug Discovery and Development

o Oncology

o Immunology

o Other Applications

7. Global Glycobiology Market Segmentation, By End User

• Global Glycobiology Market Share Analysis, By End User

• Global Glycobiology Market Growth Analysis, By End User

• Global Glycobiology Market Trends, By End User

o Pharmaceutical and Biotechnology Companies

o Contract Research Organizations

o Other End Users

8. Global Glycobiology Market Segmentation, By Region

• Global Glycobiology Market Share Analysis, By Region

• Global Glycobiology Market Growth Analysis, By Region

• Global Glycobiology Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Agilent Technologies*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Bruker Corporation

• Danaher Corporation

• Merck KGaA

• New England Biolabs

• ProZyme

• Shimadzu Corporation

• Takara Bio

• Thermo Fisher Scientific

• Waters Corporation

 *Similar analysis will be provided for each company listed above.